2m 2m 2m 2m 2m 2m 2m
Eli Lilly & Co (LLY)
NYSE
$1,116.14+$0.44 (+0.04%)
Price as of Sep 11, 2026 7:59 PM EDT- $994.5BMarket Cap
- 48.63%1-Year Change
- Drug Manufacturers - GeneralIndustry
Eli Lilly & Co (LLY)
$1,116.14+$0.44 (+0.04%)
LLY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1,115.70 | ||
Change | -$7.30 (-0.65%) | ||
Open | $1,129.40 | ||
High | $1,131.44 | ||
Low | $1,113.29 | ||
Previous Close | $1,123.00 | ||
Volume | 1,838,386 | ||
30-Day Average Volume | 2,418,996 | ||
1-Week Change | -2.93% | ||
1-Month Change | -8.04% | ||
1-Year Change | 48.63% | ||
3-Year Change | 91.24% | ||
5-Year Change | 387.48% | ||
Fundamentals | |||
Shares Outstanding | 891.4M | ||
Total Assets | $142.3B | ||
Market Cap | $994.5B | ||
Enterprise Value | $1.0T | ||
Period: QTR TTM FY | |||
Revenue | $23.0B | ||
Net Income | $7.1B | ||
Free Cash Flow | $10.7B | ||
EBIT | $9.2B | ||
EBITDA | $9.8B | ||
Net Working Capital | $16.9B | ||
EPS | $7.94 | ||
Enterprise Value/EBITDA | 106 | ||
Enterprise Value/Revenue | 45 | ||
P/B | 29 | ||
P/E | 141 | ||
PEG | -36 | ||
Price/Free Cash Flow | 93 | ||
Price/Operating Cash Flow | 93 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.62% | ||
Trailing Annual Dividend Yield | 0.60% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield